---
schema_version: "secwatch.filing_event.v1"
accession: "0000927066-26-000060"
form_type: "8-K"
ticker: "DVA"
cik: "0000927066"
company_name: "DAVITA INC."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:44:44.438741+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# DaVita Q1 2026 adj EPS $2.87 vs $2.00 YoY; revenue $3.416B, repurchased 3M shares

## Summary
- GAAP and adjusted diluted EPS $2.87, up 44% YoY from $2.00; down sequentially from $3.40 in Q4 2025.
- Consolidated revenue $3.416B; operating income $482M; operating cash flow $321M; free cash flow $140M.
- Repurchased 3.0M shares at avg price $133.70 per share during Q1 2026.
- CEO Javier Rodriguez highlighted clinical excellence and durable results; net income from continuing ops $198M.

## SEC filing metadata
- accession: 0000927066-26-000060
- form_type: 8-K
- ticker: DVA
- cik: 0000927066
- company_name: DAVITA INC.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927066/000092706626000060/0000927066-26-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927066/000092706626000060/dva-20260505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927066-26-000060
- JSON: https://secwatch.observer/filing/0000927066-26-000060.json
- Plain text: https://secwatch.observer/filing/0000927066-26-000060.txt

## Key facts
- Earnings Releases
  DAVITA INC. reported the quarter ended March 31, 2026 results: revenue $3.416 billion, net income $198 million, EPS $2.87.
  - Period: the quarter ended March 31, 2026
  - Revenue: $3.416 billion
  - Net income: $198 million
  - EPS: $2.87
  - Result: reported results
  source text: strong financial performance, and this quarter is no exception.” Financial and operating highlights for the quarter and year ended March 31, 2026: • Consolidated revenues were $3.416 billion. • Operating income was $482 million. • Diluted earnings per share from continuing operations was $2.87. • Operating cash flow was $321 million and free cash flow was $140
  evidence_url: https://www.sec.gov/Archives/edgar/data/927066/000092706626000060/0000927066-26-000060-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.